Sixty-six patients were entered into a prospective, randomized clinical trial evaluating the use of alternating noncross-resistant chemotherapy i n patients with extensive small cell carcinoma of the lung. Sixty-five were evaluable. One regimen utilized cyclophosphamide, VP-16, vincristine, cisplati
β¦ LIBER β¦
Abdominal computed tomography in small cell lung cancer: Assessment of extent of disease and response to therapy
β Scribed by Daniel C. Ihde; N. Reed Dunnick; Anita Johnston-Early; Paul A. Bunn; Martin H. Cohen; John D. Minna
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 570 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Evaluation of alternating chemotherapy a
β
Thomas R. Lininger; Thomas R. Fleming; Robert T. Eagan
π
Article
π
1981
π
John Wiley and Sons
π
English
β 669 KB
Fibrosing alveolitis in systemic scleros
β
A. U. Wells; D. M. Hansell; M. B. Rubens; A. D. King; D. Cramer; C. M. Black; R.
π
Article
π
1997
π
John Wiley and Sons
π
English
β 890 KB
Morphologic and clinical determinants of
β
James A. Strauchen; Barbara M. Egbert; Jon C. Kosek; Roy Mackintosh; Dayton S. M
π
Article
π
1983
π
John Wiley and Sons
π
English
β 612 KB
Problems in radiographic estimation of r
β
Elisabeth Quoix; Norman Wolkove; James Hanley; Harvey Kreisman
π
Article
π
1988
π
John Wiley and Sons
π
English
β 467 KB
π 2 views
Evaluation of response to chemotherapy w
β
Daniel C. Ihde; Martin H. Cohen; Elisabeth B. Simms; Mary J. Matthews; Paul A. B
π
Article
π
1980
π
John Wiley and Sons
π
English
β 384 KB
π 2 views
High rates of tumor growth and disease p
β
Sarah Everitt; Alan Herschtal; Jason Callahan; Nikki Plumridge; David Ball; Toma
π
Article
π
2010
π
John Wiley and Sons
π
English
β 237 KB
π 1 views
## Abstract ## BACKGROUND: The authors studied growth and progression of untreated nonsmall cell lung cancer (NSCLC) by comparing diagnostic and radiotherapy (RT) planning fluorodeoxyglucose (FDG)βpositron emission tomography (PET)/computed tomography (CT) scans before proposed radical chemoβRT.